Snapshot from Aug 24, 2026 at 07:00 UTC. For live data and tracking: View Live
Entities / People / Richard Meade
Person

Richard Meade

Tracked across 2 events · 396 articles · First seen Apr 20, 2026 · Last active Aug 13, 2026

Sentiment
5
Attention
9
Events
2
Relationships
0
Live sentiment trends, attention charts, and prominence tracking available on the Ergen Dashboard
Events (2)
4 0
Regulatory
Novartis wins UK Entresto patent case
On August 13, 2026, London's United Kingdom — High Court of Justiciary ruled in favor of Swiss drugmaker Novartis in a patent dispute over its blockbuster heart drug Sacubitril/valsartan. Judge Richard Meade rejected a challenge…
Impact: Judge Richard Meade presided over the case and ruled in favor of Novartis, rejecting all challenges to the patent.
Aug 13, 2026 · 6 articles
9 10
International
US-Iran Peace Deal, Hormuz Reopening
Impact: Richard Meade, editor-in-chief at Lloyd s List Intelligence, has described the US military's 'limited overwatch operation' in the Strait of Hormuz and noted the increase in opportunistic operators.
Apr 20, 2026 · 390 articles
ERGEN INTELLIGENCE
Track Richard Meade live

Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.